Google DeepMind Launches AlphaGenome Atlas for DNA Research
Google DeepMind's AlphaGenome Atlas maps billions of DNA variants, giving scientists a free AI tool to speed up genetic and disease research.
Agentic Times contributor
Maisie is a news writer at Agent Locker, covering the latest developments in artificial intelligence, emerging technology and the companies shaping the future.
Google DeepMind's AlphaGenome Atlas maps billions of DNA variants, giving scientists a free AI tool to speed up genetic and disease research.
Mistral raised €3 billion at a €21 billion valuation, led by Samsung Electronics, to expand AI infrastructure and global growth.
OpenAI says a new AI model helped solve part of a 90-year-old math problem in 88 hours, but a rival researcher disputes the timeline.
Meta launched its Muse AI agent the same day US officials accused DeepSeek, Alibaba, and other Chinese firms of copying American AI models.
Authors report publishers and literary agents wrongly claiming shares of Anthropic's $1.5 billion copyright settlement payments.
Arm launched AI Portal, a new platform giving over 22 million developers optimized AI models and tools for cloud, edge and physical AI devices.
Saudi AI firm Humain has begun IPO preparations just 16 months after launch, following a wave of major tech partnerships and investments.
Harrison.ai cut Australian jobs after receiving $32 million in government funding, while launching a paid US AI radiology service raising doctor independence concerns.
Google picked 16 Asia-Pacific groups for a new AI accelerator focused on wildlife, farming, and carbon-market projects starting in Singapore.
OpenAI released GPT-6 Astra, a new AI model with top scores on math, coding, and cybersecurity benchmarks, rolling out across ChatGPT and cloud platforms this week.
Arm's CEO says AI will help cure cancer and power humanoid robots within years, though chip shortages are slowing progress.
Trump posted AI images on Truth Social claiming huge stock gains for the U.S. and showing Iran's defeat, without providing evidence.
Read our editorial policy or contact us.